Jan de Backer, CEO and founder of FLUIDDA, has been appointed to the Board of Directors of the new global non-profit organization OSIC (Open Source Imaging Consortium).
The OSIC is a cooperative effort between academia, industry and philanthropy to enable rapid advances in the fight against Idiopathic Pulmonary Fibrosis (IPF) and other progressive interstitial lung diseases (ILD’s). Radiologists, clinicians and computational scientists from around the world will collaborate on the development of digital imaging biomarkers for accurate imaging-based diagnosis, prognosis and prediction of response to therapy.
The organization’s founding partners include Boehringer Ingelheim, Siemens Healthineers, CSL Behring, and FLUIDDA,
The partners will work in pre-competitive areas for mutual benefit and, most importantly, the benefit of patients.
“Medical images hold a lot of secrets that can now be uncovered using the newest technologies,” said Jan De Backer: “Through initiatives like OSIC, we expect to significantly accelerate ILD drug development and improve patient care in the near term.”
The goals of the OSIC are earlier diagnosis and enhanced prediction of lung disease prognosis, which will lead to better disease management.
More information about OSIC can be found on www.osicild.org.